Last reviewed · How we verify

NCT06167772: SOFA

Leucine-enriched Branched-chain Amino Acid on Muscle Thickness, Interleukin-6, SOFA Score in Critical Illness

Completed NA Last updated 23 July 2024
What this trial tests

NA trial testing BCAA in Critical Illness in 40 participants. Completed in 10 May 2024.

Timeline
14 December 2023
Primary endpoint
10 May 2024
10 May 2024

Quick facts

Lead sponsorIndonesia University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposesupportive care
Enrollment40
Start date14 December 2023
Primary completion10 May 2024
Estimated completion10 May 2024
Sites2 locations across Indonesia

Drugs / interventions tested

Conditions studied

Sponsor

Indonesia University

Who can join

Adults 18 to 65, any sex, with Critical Illness or Muscle Wasting. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial study is to test effects of leucine-enriched branched-chain amino acid (BCAA) in critically ill patients. The main questions it aims to answer are: • How are the changes in muscle thickness between groups at baseline and end of study • Is there a decrease in interleukin-6 levels between groups at baseline and end of study • Is there a decrease in sequential organ failure assessment score between groups at baseline and end of study. Participants will be given leucine-enriched branched-chain amino acid 40 g/day enterally or parenterally for 10 days. Researchers will compare with control groups to see if there is any changes between groups at baseline and end of study.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. High leucine branched-chain amino acids supplementation ameliorates quadriceps femoris muscle thickness reduction and attenuates interleukin-6 in critically ill patients: A randomised controlled trial.
    Wulandari Y, Aditianingsih D, Sunardi D, Prasetyo M, et al · · 2026 · PMID 41325937 · DOI 10.1016/j.clnesp.2025.11.153

Verify or expand the search:

Other trials of BCAA

Trials testing the same drug.

Other recruiting trials for Critical Illness

Currently open trials in the same condition.

Other Indonesia University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06167772.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing